AbbVie's profit rises 19 pct on Humira demand
July 28, 2017 at 07:50 AM EDT
July 28 (Reuters) - U.S. drugmaker AbbVie Inc reported an 18.9 percent rise in quarterly profit on Friday on strong demand for its flagship rheumatoid arthritis drug, Humira.
